Dermaseptins and magainins: Antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Hani, Khaled ^a   Zairi, Amira ^a   Tangy, Frédéric ^b   Bouassida, Khaireddine ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CECROPIN; CONTRACEPTIVE AGENT; DEFENSIN; DERMASEPTIN; DERMASEPTIN K4 S4; DERMASEPTIN S; MAGAININ 1; MAGAININ 2; MAGAININ DERIVATIVE; MELITTIN; MICROBICIDE; NONOXINOL 9; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPHEMUSIN; PROTEGRIN; SPERMICIDAL AGENT; UNCLASSIFIED DRUG; AMPHIBIAN PROTEIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; CONTRACEPTION; CYTOTOXICITY; DRUG MECHANISM; DRUG SAFETY; FUNGICIDAL ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE DAMAGE; NONHUMAN; PREGNANCY; PROTEIN STRUCTURE; REPRODUCTIVE HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON MOTILITY; UNSPECIFIED SIDE EFFECT; VAGINA EPITHELIUM; XENOPUS LAEVIS; ANIMAL; CHEMISTRY; FEMALE; FROG; MALE; METABOLISM; SKIN;

ANURA; HUMAN IMMUNODEFICIENCY VIRUS; PHYLLOMEDUSA SAUVAGEI; XENOPUS LAEVIS;

AMPHIBIAN PROTEINS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HUMANS; MAGAININS; MALE; RANIDAE; SEXUALLY TRANSMITTED DISEASES; SKIN; SPERMATOCIDAL AGENTS;

EID: 71149119140     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/452567     Document Type: Review

References (64)

1. Dcruz O. J., Uckun F. M., Clinical development of microbicides for the prevention of HIV infection Current Pharmaceutical Design 2004 10 30 315 336
2. Poynten I. M., Millwood I. Y., Falster M. O., The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies AIDS 2009 23 10 1245 1254
3. CDCP update, US HIV and AIDS cases reported through December 1996. HIV/AIDS Surveillance Report 8; 1-133, 1997
4. Weber J., Nunn A., Connor O., Chemical condoms for the prevention of HIV infection: evaluation of novel agents against SHIV (89.6 pd) in vitro and in vivo AIDS 2001 15 18 1563 1568
5. Zaneveld L. J. D., Anderson R. A., Diao X.-H., Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis Fertility and Sterility 2002 78 5 1107 1115
6. DCruz O. J., Venkatachalam T. K., Uckun F. M., Structural requirements for potent human spermicidal activity of dual- function aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI- 07) Biology of Reproduction 2000 62 1 37 44
7. Hillier S. L., Moench T., Shattock R., Black R., Reichelderfer P., Veronese F., In vitro and in vivo: the story of nonoxynol 9 Journal of Acquired Immuno Deficiency Syndromes 2005 39 1 1 8
8. Uckun F. M., DCruz O. J., Prophylactic contraceptives for HIV/AIDS Human Reproduction Update 1999 5 5 506 514
9. Roddy R. E., Zekeng L., Ryan K. A., Tamouf U., Tweedy K. G., Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial Journal of the American Medical Association 2002 287 9 1117 1122
10. D'Cruz O. J., Uckun F. M., Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles Contraception 2001 64 2 113 123
11. Krebs F. C., Miller S. R., Catalone B. J., Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes Antimicrobial Agents and Chemotherapy 2000 44 7 1954 1960
12. Rosenstein I. J., Stafford M. K., Kitchen V. S., Ward H., Weber J. N., Taylor-Robinson D., Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1 Journal of Infectious Diseases 1998 177 5 1386 1390
13. Stafford M. K., Ward H., Flanagan A., Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects Journal of Acquired Immuno Deficiency Syndromes and Human Retrovirology 1998 17 4 327 331
14. Reddy K. V. R., Yedery R. D., Aranha C., Antimicrobial peptides: premises and promises International Journal of Antimicrobial Agents 2004 24 6 536 547
15. Hultmark D., Drosophila immunity: paths and patterns Current Opinion in Immunology 2003 15 1 12 19
16. Bals R., Epithelial antimicrobial peptides in host defense against infection Respiratory research 2000 1 3 141 150
17. Brown K. L., Hancock R. E., Cationic host defense (antimicrobial) peptides Current Opinion in Immunology 2006 18 1 24 30
18. Zhang L., Yu W., He T., Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor Science 2002 298 5595 995 1000
19. Qu X., Harwig S. L., Oren A., Susceptibilty of Neisseria gonorrhoeae to protegrins Infection and Immunity 1996 65 636 639
20. Yasin B., Harwig S. L., Lehrer R. I., Wagar E. A., Susceptibility of Chlamydia trachomatis to protegrins and defensins Infection and Immunity 1996 64 3 709 713
21. Sutyak K. E., Anderson R. A., Dover S. E., Spermicidal activity of the safe natural antimicrobial peptide subtilosin Infectious Diseases in Obstetrics and Gynecology 2008 2008 1 6
22. Aranha C., Gupta S., Reddy K. V. R., Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies Contraception 2004 69 4 333 338
23. Zasloff M., Martin B., Chen H.-C., Antimicrobial activity of synthetic magainin peptides and several analogues Proceedings of the National Academy of Sciences of the United States of America 1988 85 3 910 913
24. Reddy K. V. R., Shahani S. K., Meherji P. K., Spermicidal activity of magainins: in vitro and in vivo studies Contraception 1996 53 4 205 210
25. Zairi A., Tangy F., Ducos-Galand M., Alonso J.-M., Hani K., Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives Diagnostic Microbiology and Infectious Disease 2007 57 3 319 324
26. Zairi A., Tangy F., Saadi S., Hani K., In vitro activity of dermaseptin S4 derivatives against genital infections pathogens Regulatory Toxicology and Pharmacology 2008 50 3 353 358
27. Zairi A., Belad A., Gahbiche A., Hani K., Spermicidal activity of dermaseptins Contraception 2005 72 6 447 453
28. Caporale L. H., Chance favors the prepared genome Annals of the New York Academy of Sciences 1999 870 1 21
29. Severini C., Importa G., Falconieri-Erspamer V., Salvadori S., Erspamer V., The tachykinin peptide family Pharmacological Reviews 2002 54 285 322
30. Simmaco M., Mignogna G., Barra D., Antimicrobial peptides from amphiban skin: what they tell us? Biopolymers 1998 47 435 450
31. Lacombe C., Cifuentes-Diaz C., Dunia I., Auber-Thomay M., Nicolas P., Amiche M., Peptide secretion in the cutaneous glands of South American tree frog Phyllomedusa bicolor: an ultrastructural study European Journal of Cell Biology 2000 79 9 631 641
32. Jacob L., Zasloff M., Potential therapeutic applications of magainins and other antimicrobial agents of animal origin Ciba Foundation Symposium 1994 186 197 223
33. Zasloff M., Antimicrobial peptides in health and disease The New England Journal of Medicine 2002 347 1151 1160
34. Dulleman W. E., Trueb L., Biology of Amphibians 1994 25th London, UK John Hopkins University Press
35. van Compernolle S. E., Taylor R. J., Oswald-Richter K., Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells Journal of Virology 2005 79 18 11598 11606
36. Giovannini M. G., Poulter L., Gibson B. W., Williams D. H., Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones Biochemical Journal 1987 243 1 113 120
37. Zasloff M., Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor Proceedings of the National Academy of Sciences of the United States of America 1987 84 15 5449 5453
38. Sai K. P., Reddy P. N., Babu M., Investigations on wound healing by using amphibian skin Indian Journal of Experimental Biology 1995 33 9 673 676
39. Clara A., Manjramkar D. D., Reddy V. K., Preclinical evaluation of magainin-A as a contraceptive antimicrobial agent Fertility and Sterility 2004 81 5 1357 1365
40. Albiol Matanic V. C., Castilla V., Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus International Journal of Antimicrobial Agents 2004 23 4 382 389
41. Egal M., Conrad M., MacDonald D. L., Maloy W. L., Motley M., Genco C. A., Antiviral effects of synthetic membrane-active peptides on herpes simplex virus, type 1 International Journal of Antimicrobial Agents 1999 13 1 57 60
42. Reddy V. R. K., Manjramkar D. D., Evaluation of the antifertility effect of magainin-A in rabbits: in vitro and in vivo studies Fertility and Sterility 2000 73 2 353 358
43. Zatuchni B., Hahn D. W., Zaneveld L. J. D., Postcoital, vaginal, spermicidal potency of formulations: the Macaca arctoides (stumptailed macaque) as animal model Fertility and Sterility 1981 35 6 683 690
44. Zairi A., Serres C., Tangy F., Jouannet P., Hani K., In vitro spermicidal activity of peptides from amphibian skin: dermaseptin S4 and derivatives Bioorganic Medicinal Chemistry 2008 16 1 266 275
45. Mor A., Nicolas P., Isolation and structure of novel defensive peptides from frog skin European Journal of Biochemistry 1994 219 1-2 145 154
46. Mor A., Hani K., Nicolas P., The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms The Journal of Biological Chemistry 1994 269 50 31635 31641
47. Lequin O., Ladram A., Chabbert L., Dermaseptin S9, an α-helical antimicrobial peptide with a hydrophobic core and cationic termini Biochemistry 2006 45 2 468 480
48. Navon-Venezia S., Feder R., Gaidukov L., Carmeli Y., Mor A., Antibacterial properties of dermaseptin S4 derivatives with in vivo activity Antimicrobial Agents and Chemotherapy 2002 46 3 689 694
49. Kustanovich I., Shalev D. E., Mikhlin M., Gaidukov L., Mor A., Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives The Journal of Biological Chemistry 2002 277 19 16941 16951
50. Feder R., Dagan A., Mor A., Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerisation on selective cytotoxicity The Journal of Biological Chemistry 2000 275 4230 4238
51. Krugliak M., Feder R., Zolotarev V. Y., Antimalarial activities of dermaseptin S4 derivatives Antimicrobial Agents and Chemotherapy 2000 44 9 2442 2451
52. Naglik J. R., Challacombe S. J., Hube B., Candida albicans secreted aspartyl proteinases in virulence and pathogenesis Microbiology and Molecular Biology Reviews 2003 67 3 400 428
53. Venev S., Experimental abortions in mice and guinea pigs caused by Aspergillus fumigatus spores Veterinarno-Meditsinski Nauki 1976 13 1 86 93
54. Hernandez C., Mor A., Dagger F., Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin European Journal of Cell Biology 1992 59 2 414 424
55. Dagan A., Efron L., Gaidukov L., Mor A., Ginsburg H., In vitro antiplasmodium effects of dermaseptins Antimicrob Agents Chemother 2002 46 1059 1066
56. Efron L., Dagan A., Gaidukov L., Ginsburg H., Mor A., Direct interaction of dermaseptin S4 aminoheptanoyl derivate with intra-erythrocytic malaria parasite leading to increased specific antiparasitic activity in culture The Journal of Biological Chemistry 2002 277 24067 24072
57. Coote P. J., Holyoak C. D., Bracey D., Ferdinando D. P., Pearce J. A., Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae Antimicrobial Agents and Chemotherapy 1998 42 9 2160 2170
58. Lorin C., Saidi H., Belaid A., Zairi A., Baleux F., Hocini H., The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro Virology 2005 334 2 264 275
59. Rydlo T., Sotem S., Mor A., Antibacterial 1 properties of dermaseptin S4 derivatives under extreme incubation conditions Antimicrobial Agents and Chemotherapy 2006 50 2 490 507
60. Andres E., Dimarq J. L., Clinical development of antimicrobial peptides The International Journal of Antimicrobial Agents 2005 25 448 449
61. Levy O., Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents Blood 2000 96 8 2664 2672
62. Gura T., Innate immunity: ancient system gets new respect Science 2001 291 5511 2068 2071
63. Paquette D. W., Simpson D. M., Friden P., Braman V., Williams R. C., Safety and clinical effects of topical histatin gels in humans with experimental gingivitis Journal of Clinical Periodontology 2002 29 12 1051 1058
64. Hancock R. E. W., Host defence (cationic) peptides. What is their future clinical potential? Drugs 1999 57 469 473